PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026ERJ Open Research0 citationsOpen Access

The addition of radial endobronchial ultrasound to electromagnetic navigation bronchoscopy: the NEBULA study—a randomized controlled trial

View Full Paper
AJAmanda Dandanell JuulAAArman ArshadACAlice V Christophersen

Key Points

  • Investigate if combining radial endobronchial ultrasound with electromagnetic navigation improves diagnosis of suspected lung cancer.
  • Randomized controlled trial comparing ENB and ENB+rEBUS.
  • Conducted following CONSORT guidelines.
  • Reference standard included histopathologic diagnosis and CT surveillance.
  • Analyses based on intention-to-treat.
  • 200 patients included; 183 randomized for final analysis.
  • No significant difference in diagnostic yield (43.8% vs 45.7%).
  • No differences in malignant yield or adverse events reported.

Abstract

Background Bronchoscopic biopsies are a valuable tool for diagnosing small peripheral lung lesions suspected of cancer. Electromagnetic Navigation Bronchoscopy (ENB) has been developed to guide the bronchoscopist to the lesion and Radial Endobronchial Ultrasound (rEBUS) to confirm the presence lesion once reached. The combination of modalities might improve the diagnostic yield; however, only a few studies with diverting results have been published. Objective To investigate whether the combination of rEBUS and ENB is superior to ENB alone for diagnosing peripheral lung lesions suspected of lung cancer in a pragmatic study setting representing the daily clinical practices and challenges. Methods The study was conducted according to CONSORT guidelines. All patients were randomized for either ENB or ENB+rEBUS. The reference test was either a final histopathologic diagnosis or determined by six months of CT surveillance. Analyses were performed using intention-to-treat, with only procedures with a definitive diagnosis categorized as “diagnostic.” Results Of 200 patients included from four centers, 183 were randomized and included in the final analyses. There was no difference in diagnostic yield between the two groups, (43.8 versus 45.7); nor did we find any difference in malignant yield or adverse events. Conclusion ENB+rEBUS is a safe and well tolerated procedure, but not superior to ENB alone.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Juul et al. (2026) studied this question.

synapsesocial.com/papers/6996a7d3ecb39a600b3edf17https://doi.org/10.1183/23120541.01494-2025
Ask AI
Helpful
Bookmark
Share
View Full Paper